Imara to Present at 11th Annual SVB Leerink Global Healthcare Conference
10. Februar 2022 07:00 ET
|
Imara, Inc.
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
InflaRx to Present at Annual SVB Leerink Global Health Conference
08. Februar 2022 07:30 ET
|
InflaRx N.V.
JENA, Germany, Feb. 08, 2022 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system,...
Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference
07. Februar 2022 16:05 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Aptinyx to Present at Upcoming Virtual Investor Conferences
16. Juni 2020 08:37 ET
|
Aptinyx Inc.
EVANSTON, Ill., June 16, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
ASLAN Pharmaceuticals to Present at 9th Annual SVB Leerink Global Healthcare Conference
24. Februar 2020 02:05 ET
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Feb. 24, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company, today announced its...
Aptinyx to Present at Upcoming Investor Conferences
19. Februar 2020 08:37 ET
|
Aptinyx Inc.
EVANSTON, Ill., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
Mayfield Pharmaceuticals to Present at the SVB Leerink New Treatments Focused on Women’s Health Conference on October 10, 2019
08. Oktober 2019 07:35 ET
|
Harrow Health, Inc.
BOSTON, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its Chief Executive Officer, Melissa...